He then takes a course of action based on it. Antagonists have already been synthesized for LTD4 and LTE4. Herron says that some of them have been tested in people, and they have been accepted in the world of medicine as effective. Herron is especially interested in developing an anta-gonist for LTC4, as no one in the world has yet discovered one. That discovery may lead to a new, more powerful type of mass-produced asthma drug.
Antagonists are potentially very safe, because they are very specific.
More information from the NCSA Digital Library database.